U.S. judge schedules 2019 trial in opioid litigation

(Reuters) - A federal judge pushing for a settlement in lawsuits seeking to hold drug companies responsible for their roles in the U.S. opioid epidemic on Wednesday set an aggressive schedule that would have the first trial take place in March 2019.

J&J, Imerys unit must pay $117 million in N.J. asbestos cancer case

NEW YORK (Reuters) - Johnson & Johnson and Imerys Talc America, a unit of Imerys SA, must pay $117 million in damages in a case involving a man who said he developed cancer due to his exposure to asbestos in talc-based products, a New Jersey state court jury said on Wednesday.

EU court adviser says ban on Swedish snuff tobacco product valid

BRUSSELS (Reuters) - An EU ban on the sale of snus, a wet snuff tobacco product made by Swedish Match, is valid, an adviser to the European Union's top court said on Thursday.

GSK slims portfolio with sale of rare disease gene therapy drugs

LONDON (Reuters) - GlaxoSmithKline is divesting its rare disease gene therapy drugs to Orchard Therapeutics, it said on Thursday, as Chief Executive Emma Walmsley makes good on her promise to prune the drugmaker's pharmaceuticals portfolio.

Healthcare group Sanofi to invest 350 million euros in Canada vaccine facility

PARIS (Reuters) - French healthcare group Sanofi is investing 350 million euros ($432.4 million) in a Canadian vaccine facility, which the drugmaker said would help it meet growing demand in this area.

U.S. FDA approves AI device to detect diabetic eye disease

(Reuters) - U.S. health regulators said on Wednesday it will allow sale of the first medical device that uses artificial intelligence (AI) software to detect greater than a mild level of the most common cause of vision loss among more than 30 million Americans living with diabetes.

Biotech M&A rolls on as Alexion snaps up Wilson for $855 million

(Reuters) - Alexion Pharmaceuticals has agreed to buy Sweden's Wilson Therapeutics for 7.1 billion Swedish crowns ($855 million), boosting its line-up of rare disease drugs as a wave of deal-making in the biotechnology sector continues.

New weapon in malaria fight: a better bed net

LONDON (Reuters) - A new kind of bed net that blocks mosquitoes' resistance to a common insecticide provides substantially improved protection against malaria, a major study has found.

Hospitals must support breastfeeding which saves lives - WHO, UNICEF

GENEVA (Reuters) - Babies, even those who are premature, underweight or sickly, should be exclusively breastfed, from the maternity ward and ideally for two years, the U.N. agencies said on Wednesday.

ACLU sues to block new Kentucky law restricting abortions

LOUISVILLE (Reuters) - A civil rights group on Wednesday sued to block a Kentucky law that restricts abortion access in the state a day after the governor signed the bill.

Related Videos

Recycled plastic pavements put Ghana on eco-friendly path

Island of plastic garbage in Pacific 16 times bigger than thought - study

You might like...

Check out our Reuters News Now daily briefing for hand-picked stories from Reuters editors. It's all the news you need to start your day.

Subscribe here